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To ascertain whether predischarge arteriography is beneficial in 
patients with acute myocardial infarction treated with recombi-
nant tissue-type plasminogen activator (rt-PA), heparin and aspi-
rin, the outcome of 197 patients in the Thrombolysis in Myocar-
dial Infarction (TIMI) IIA study assigned to conservative 
management and routine predischarge coronary arteriography 
(routine catheterization group) was compared with the outcome of 
1,461 patients from the TIMI lIB study assigned to conservative 
management without routine coronary arteriography unless isch-
emia recurred spontaneously or on predischarge exercise testing 
(selective catheterization group). The two groups were similar 
with regard to important baseline variables. 
During the initial hospital stay, coronary arteriography was 
performed in 93.9% of the routine catheterization group and 
34.7% of the selective catheterization group (p < 0.001), but the 
frequency of coronary revascularization (angioplasty or coronary 
artery bypass surgery) was similar in the two groups (24.4% 
versus 20.7%, p = NS). Coronary arteriograms showed a pre-
dominance of zero or one vessel disease (stenosis ~60%) in both 
Over the past decade, it has become standard practice in 
many hospitals to perform predischarge coronary arteriog-
raphy routinely in patients convalescing from acute myocar-
dial infarction, especially those treated initially with intrave-
nous thrombolytic therapy and managed conservatively (1,2). 
The rationale for routine postinfarction arteriography is that 1) 
it defines the coronary anatomy responsible for the infarction 
and provides insight into the success of thrombolytic therapy, 
if administered; 2) it provides the potential to prevent reinfarc-
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groups (routine catheterization group 73.1 %, selective catheter-
ization group 61.3 %). During the 1st year after infarction, 
rehospitalization for cardiac reasons and the interim performance 
of coronary arteriography were more common in the selective 
catheterization group (37.9% versus 27.6%, p = 0.007 and 28.6% 
versus 11.6%, p < 0.001, respectively); however, the interim rates 
of death, nonfatal reinfarction and performance of coronary 
revascularization procedures were similar. 
At the end of 1 year, coronary arteriography had been 
performed one or more times in 98.9% of the routine catheteriza-
tion group and 59.4% of the selective catheterization group (p < 
0.001), whereas death and nonfatal reinfarction had occurred in 
10.2% versus 7.0% (p = 0.10) and 8.6% versus 9.0% (p = 0.87), 
respectively. Because the selective coronary arteriography policy 
exposes about 40% fewer patients to the small but finite risks and 
inconvenience of the procedure without compromising the 1 year 
survival or reinfarction rates, it seems to be an appropriate 
management strategy. 
(J Am Coil CardioI1991;17:1007-16) 
tion and premature death by identifying for subsequent me-
chanical revascularization subsets of patients with "high risk" 
coronary anatomy, such as those with left main or three vessel 
coronary artery disease or large zones of viable myocardium 
jeopardized by stenotic coronary arteries (3); and 3) the knowl-
edge of coronary anatomy may allow more prompt institution 
of appropriately tailored therapy, shortening hospitalization 
and subsequent convalescence (4) and perhaps preventing 
cardiac readmissions. 
However, rather than routine postinfarction arteriogra-
phy, some reports (5,6) have advocated a more selective 
approach, targeting coronary arteriography to patients with 
a specific clinical indication such as recurrent ischemia, thus 
avoiding the risks and expense of the procedure in patients 
having no specific indication for it and helping to curb 
"reperfusion momentum" (7), the tendency to revascularize 
all lesions visualized, regardless of significance. 
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The purpose of this report is to compare the outcome of 
the routine and selective predischarge arteriography strate-
gies in two conservatively managed subgroups of patients 
entered into the Thrombolysis in Myocardial Infarction 
(TIMI) Phase II study. In one group, termed the routine 
catheterization group, predischarge coronary arteriography 
was mandated by protocol; whereas, in the other group, 
termed the selective catheterization group, predischarge 
arteriography was advised only for pressing clinical indica-
tions such as spontaneous or exercise-induced recurrent 
ischemia. 
Methods 
Study design and patients. The study group consisted of 
patients allocated to conservative management in the 
Thrombolysis in Myocardial Infarction (TIMI) I1A and lIB 
trials. Detailed descriptions of the design and findings of 
these trials have been previously published (8,9). Briefly, the 
primary objective of the TIMI II trials was to assess the role 
and timing of percutaneous transluminal coronary angio-
plasty in patients with acute myocardial infarction treated 
with recombinant tissue-type plasminogen activator. In 
these trials, patients were randomized to either an invasive 
strategy in which coronary arteriography and angioplasty, if 
appropriate, were done early after rt-PA administration or to 
a conservative management strategy in which coronary 
arteriography was performed only for specific clinical indi-
cations such as recurrent ischemia. In the TIMI lIA trial, 
predischarge contrast left ventriculographic ejection fraction 
was the primary end point and therefore all patients, even 
those in the conservative management group, were required 
to undergo predischarge cardiac catheterization. In the 
larger TIMI lIB trial, the primary end point was the occur-
rence of death and reinfarction at 6 weeks after entry into the 
study; thus, predischarge cardiac catheterization was per-
formed only if there were clinical indications. 
The purpose of this report is to assess the role of 
predischarge coronary arteriography in patients initially 
managed with intravenous thrombolytic therapy without 
early coronary arteriography. Therefore, the present study 
focuses solely on the outcome of the parallel subsets of 
patients assigned to conservative management in the TIMI 
lIA trial (termed the routine catheterization group) and lIB 
trial (termed the selective catheterization group). 
Patients were eligible for TIMI II if they were <76 years 
of age, had ischemic chest pain of dO min duration and ST 
elevation 2:0.1 m V in at least two contiguous electrocardio-
graphic (ECG) leads, gave written informed consent, could 
have rt-PA therapy initiated within 4 h of onset of acute 
myocardial infarction symptoms and had none of the exclu-
sion criteria shown in Table I. 
The TIMI lIA patients were recruited between April II, 
1986 and September 24, 1987 at seven hospitals with special 
interest and proficiency in immediate angioplasty for acute 
myocardial infarction. The TIMI lIB patients were recruited 
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Table 1. Thrombolysis in Myocardial Infarction Phase II 
(TIMI II) Trial Exclusion Criteria 
Cerebrovascular disease (including any form of stroke or TIA) 
BP > 180 mm Hg systolic or > I IO mm Hg diastolic 
Bleeding disorder 
Surgery within the previous 2 weeks 
Recent prolonged (> I min) cardiopulmonary resuscitation 
PTCA or severe trauma within 6 months 
Prior CABG or prosthetic heart valve replacement 
Left bundle branch block 
Dilated cardiomyopathy 
Infusion of any thrombolytic therapy for AMI within past 2 weeks 
Childbearing potential (premenopausal) 
Other serious advanced illness such as cancer or severe renal or hepatic 
dysfunction 
Oral anticoagulation therapy 
Psychological or physical inability to participate (including drug abuse, 
altered mental status, inability to give informed consent) 
Prior participation in TIMI II trial 
AMI = acute myocardial infarction; BP = blood pressure; CABG = 
coronary artery bypass graft surgery; PTCA = percutaneous transluminal 
coronary angioplasty; TIA = transient ischemic attack. 
between April II, 1986 and June 30, 1988 at 43 additional 
hospitals. After termination of TIMI I1A recruitment in 
September 1987, the seven hospitals previously recruiting 
patients for the TIMI lIA trial began to recruit patients for 
the TIMI lIB trial. Thus, the routine catheterization group 
consisted of patients recruited exclusively from the 7 hospi-
tals performing the TIMI IIA protocol whereas the selective 
catheterization group was composed of l) patients recruited 
from the 43 hospitals performing the TIMI liB protocol 
through September 24, 1987, and 2) patients from the com-
bined 50 hospitals performing the TIMI lIB protocol after 
September 24, 1987. The Committee on Human Research at 
each participating hospital approved the study protocol 
before patient recruitment. 
Administration of rt-PA and ancillary therapy. Patients 
received intravenous rt-PA (supplied by Genentech) over 6 h 
in a dose of 100 or 150 mg, as previously described (8,9). 
Before rt-P A administration, patients were prospectively 
classified by acute myocardial infarction "risk status" (8). 
Immediately after initiation of rt-PA, heparin (5,000 U) was 
given as an intravenous bolus injection, followed by a 5 day 
intravenous heparin infusion with dosage titrated to maintain 
the activated partial thromboplastin time 1.5 to 2.0 times the 
upper limit of normal. Beginning on day 6, heparin (10,000 U 
every 12 h) was administered subcutaneously, continuing 
until the patient underwent a predischarge exercise test. 
Aspirin was administered at a dose of 81 mg/day begin-
ning on day I (235 patients) or day 2 (l, 132 patients) and then 
increased to 325 mg/day on day 6. On initial presentation, all 
patients received sublingual nitroglycerin, morphine and 
prophylactic intravenous lidocaine, unless contraindicated. 
Ancillary nifedipine and metoprolol therapy differed be-
tween the routine catheterization and selective catheteriza-
tion groups. Nifedipine (10 to 20 mg three times daily) was 
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administered for 96 h to TIMI IIA patients undergoing 
angioplasty to prevent coronary spasm and was adminis-
tered to the remaining IIA patients (including the routine 
catheterization group) in the same dosage to render them 
comparable. Prophylactic nifedipine was not utilized in the 
TIMI lIB protocol (selective catheterization group). 
In the selective catheterization group, patients received 
metoprolol (50 to 100 mg twice daily) unless contraindicated, 
commencing on day 6 before exercise testing; as part of a 
substudy, 334 patients received metoprolol intravenously 
(:s15 mg) immediately after initiation of rt-PA and treatment 
with daily oral maintenance metoprolol (50 to 100 mg twice 
daily) was immediately begun. In the TIMI IIA protocol 
(routine catheterization group), metoprolol was adminis-
tered only as oral maintenance therapy and was not initiated 
until day 8 to 10, after exercise testing and contrast left 
ventriCUlography, so that beta-adrenergic blockade would 
not influence the primary end point, ejection fraction. 
Classification of events. Episodes of recurrent chest pain, 
ECG changes or an increase in cardiac enzymes were 
reviewed by an independent Mortality and Morbidity Clas-
sification Committee that used predetermined definitions to 
classify such events as definite myocardial infarction, recur-
rent ischemia or no event (10). 
Limited exercise testing. Patients underwent supine rest 
and bicycle exercise radionuclide ventriculography on day 8 
to 10 after study entry to assess simultaneously left ventric-
ular function and the clinical response to submaximal 
exercise. After in vivo red blood cell labeling with techne-
tium-99m pertechnetate (11), equilibrium radionuclide ven-
triculography was performed at rest and then during 3 min 
stages of 200 and 400 kilopond m/min work load. The 
exercise test was terminated after two stages or if there was 
occurrence of one or more of the following: 1) heart rate of 
~120 beats/min; 2) complex ventricular arrhythmias; 3) 
angina pectoris; 4) >20 mm Hg decrease in blood pressure; 
5) exhaustion or marked dyspnea; or 6) ~2 mm ST segment 
depression 0.08 s after J point compared with the rest ECG. 
Radionuclide data on magnetic tape or 8 in. (20 cm) floppy 
disks were forwarded from each clinical center to the TIMI 
Radionuclide Core Laboratory for analysis. 
Coronary arteriography. In the routine catheterization 
group after the radionuclide studies, coronary arteriograms 
in multiple standardized projections were obtained (along 
with contrast left ventriculograms) and forwarded to the 
TIMI Radiographic Core Laboratory for analysis. In the 
selective catheterization group, the protocol discouraged 
coronary arteriography unless the patient developed sponta-
neous recurrent ischemia or had evidence of ischemia on the 
exercise test. 
Follow-up at 6 weeks and 1 year. Rest and exercise 
radionuclide ventriculography was repeated at 6 weeks 
(window 6 to 12 weeks). Exercise at 6 weeks was continued 
until a limiting symptom occurred or until age-predicted 
(220 beats/min minus age) maximal heart rate was achieved. 
At I year after study entry (window 12 to 18 months), a 
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history of interim rehospitalizations, clinical events and 
procedures was elicited. 
Statistical methods. For discrete data variables, compar-
isons between routine catheterization and selective catheter-
ization in the proportions of patients having the given 
attribute were tested with the use of a chi-square test. For 
continuous data variables, comparisons between the groups 
were tested using a two-tailed Student's t test of mean 
values. Cumulative event rates were estimated by the prod-
uct-limit (Kaplan-Meier) method (12) and comparisons in the 
event distributions over time between the routine and selec-
tive catheterization groups were made with use of the 
log-rank statistic. All analyses were performed with use of 
SAS programs (13). Comparison between the routine and 
selective catheterization groups is not based on a compari-
son of randomized groups. To adjust for mUltiple testing and 
account for the fact that none of these analyses were for 
comparisons of randomized groups, p values between 0.01 
and 0.001 provide some evidence of differences between the 
groups and p values <0.001 provide strong evidence of a 
difference. 
Results 
Baseline characteristics (Table 2). Although patients were 
not randomized between the routine and selective catheter-
ization groups, their baseline characteristics were similar. A 
slight racial imbalance between the two groups was noted. 
The majority of the patients were categorized as "not low 
risk," primarily because of ECG changes of anterior acute 
myocardial infarction, history of prior myocardial infarction 
or advanced age. Chest pain was still ongoing in 88% of each 
group when recombinant tissue-type plasminogen activator 
(rt-PA) was initiated. The time interval between onset of 
pain to onset of rt-PA infusion was slightly but significantly 
longer (2.9 versus 2.6 h, p < 0.(01) in the routine catheter-
ization group. 
Clinical events during initial hospitalization (Table 3). 
Clinical events suggesting a need for coronary arteriography 
occurred equally in the routine and selective catheterization 
groups. Specifically, the prevalence of chest pain persisting 
after the 6 h rt-PA infusion, recurrent chest pain, nonfatal 
reinfarction and other in-hospital hemodynamically impor-
tant complications were similar between the two groups. 
Among patients undergoing exercise testing, there were 
more positive tests in those in the routine catheterization 
group, in whom beta-adrenergic blocker therapy was de-
ferred until after testing. 
Performance of coronary arteriography (Table 4). Coro-
nary arteriography was performed in 185 (94%) ofthe routine 
catheterization group and in 507 (35%) of the selective 
catheterization group (p < 0.(01). Of the 12 patients in the 
routine catheterization group not having predischarge arte-
riography, 9 died during the initial hospitalization and 3 
refused the procedure. When performed, arteriography was 
done significantly earlier in patients in the selective cathe-
1010 ROGERS ET AL. 
PREDISCHARGE CORONARY ARTERIOGRAPHY 
Table 2. Baseline Characteristics and Initiation of Therapy in the 
Two Patient Groups 
Routine Selective 
Catheterization Catheterization 
(n = 197) (n = 1,461) 
No. % No. % p Value 
Mean age (yr) 56 57 0.59 
White race 190 % 1,281 88 <0.001 
Male gender 170 86 1,190 81 0.10 
Not low risk 127 64 992 68 0.33 
Age ~70 years 22 II 159 11 0.90 
Prior MI 33 17 201 14 0.26 
Anterior MI 102 52 778 53 0.70 
Rales ~33% lung field 8 4 63 4 0.87 
Hypotension and sinus 6 3 88 6 0.09 
tachycardia 
Atrial fibrillation or flutter 2 I 37 2 0.19 
Pulmonary edema 2 13 I 0.39 
Cardiogenic shock 3 2 21 0.93 
History of 
Angina 100 51 718 49 0.67 
CHF 7 4 32 2 0.24 
Hypertension 67 34 557 38 0.26 
Diabetes mellitus 32 16 190 13 0.21 
Ongoing chest pain at rt-PA 174 88 1,289 88 0.97 
initiation 
Mean time from onset of 2.9 2.6 <0.001 
pain to rt-PA initiation 
(study entry) (h) 
CHF = congestive heart failure; MI = myocardial infarction; rt-PA = 
recombinant tissue-type plasminogen activator. 
terization group (6.2 versus 8.2 days after entry, p < 0.001), 
in whom the procedure was allowed only for pressing clinical 
indications. 
In a hierarchical analysis of reasons for the performance 
of coronary arteriography (Fig. J), the primary indication for 
the procedure in the selective catheterization group was 
recurrent ischemia (spontaneous ischemia, reinfarction or 
positive exercise test), occurring in 352 patients (24.1 % of 
the selective catheterization group). Other potential indica-
tions for arteriography such as heart failure, shock, ventric-
ular septal rupture, mitral regurgitation, cardiac arrest, chest 
pain persisting after rt-PA infusion was completed, inade-
quate duration of exercise or failure to perform the exercise 
test accounted for 64 patients undergoing arteriography 
(4.4% of the selective catheterization group). Patient or 
physician preference dictated performance of coronary arte-
riography in 91 patients (6.2% of the selective catheteriza-
tion group). 
Coronary arteriographic findings (Table 4). The distribu-
tion of the number of major coronary arteries with stenosis 
~60% differed between the routine and selective catheter-
ization groups. Although there was a predominance of single 
vessel disease in both groups, there was more multivessel 
disease among those undergoing arteriography in the selec-
tive catheterization group. Left main coronary artery steno-
lACC Vol. 17, No.5 
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Table 3. Clinical Events During Initial Hospitalization in the Two 
Patient Groups 
Routine Selective 
Catheterization Catheterization 
(n = 197) (n = 1,461) 
No. % No. % p Value 
Chest pain persisting after 38/195 19 302/1,453 21 0.67 
rt-PA infusion 
In-hospital complications* 
Chest pain 56 28 411 28 0.93 
Nonfatal reinfarction 7 4 58 4 0.78 
CHF 39 20 248 17 0.33 
Cardiogenic shock 10 5 78 5 0.88 
Ventricular septal rupture 1 0.5 2 0.1 0.25 
Mitral regurgitation 3 2 14 0.46 
Cardiac arrest 17 9 81 6 0.09 
Exercise test findings 
Exercise test performedt 153 78 1,190 81 
Chest pain during test 111153 7 6411,190 5 
ST depressiont 32/153 21 16711,189 14 
EF decrease 2:5% 211132 16 137/1,014 14 
Any of above (positive 50/153 33 299/1,190 25 0.05 
test) 
Inadequate duration of 22/153 14 15111,190 13 0.56 
exercise « stage 2) 
*Refers to complications occurring within 1st 10 days of hospitalization. 
All percents are crude event rates. tExercise tests were not performed in 44 
patients in the routine catheterization group (of whom 13 died during the initial 
hospitalization) and 271 patients in the selective catheterization group (of 
whom 52 died during the initial hospitalization). tLocal clinic assessment of 
ischemic ST segment depression. EF = ejection fraction; other abbreviations 
as in Figure 2. 
sis was detected in a higher proportion of patients in the 
routine catheterization group, but ~60% stenosis of the left 
main coronary artery and total occlusion of the infarct-
related artery was found with equal frequency. 
Complications of coronary arteriography and revascular-
ization procedures (Table 5). In both groups, catheteriza-
tion-related complications were infrequent. In keeping with 
the conservative management strategy common to both the 
routine and selective catheterization groups, coronary artery 
revascularization procedures were performed infrequently 
during the initial hospitalization: angioplasty in 17% and 13% 
and bypass surgery in 10% and 9%, respectively. Angio-
plasty-related complications were infrequent in both groups; 
there were nonsignificant trends toward more angioplasty-
related myocardial infarction and emergency bypass surgery 
in the routine catheterization group. However, bypass sur-
gery-related complications occurred with equal frequency in 
the two groups. 
Radionuclide left ventriculography (Table 6). Both at hos-
pital discharge and at 6 week follow-up study, the routine 
and selective catheterization groups had similar values for 
both global and segmental (infarct zone) ejection fraction. 
In-hospital death and clinical events (Table 7). During the 
initial hospitalization, death occurred about twice as often in 
the routine catheterization group as in the selective cathe-
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Table 4. Coronary Arteriographic Findings (Core Laboratory 
Assessment) in the Two Patient Groups 
Coronary 
arteriography 
performed during 
initial 
hospitalization 
Time from study entry 
to arteriography 
(days) 
No. of major coronary 
arteries with 
stenosis 2:60% 
o 
I 
2 
3 
Total 
Any stenosis in 
LMCA 
Stenosis 2':60% in 
LMCA 
Occluded infarct-
related artery 
(TIMI flow grade 0 
or I) 
Routine 
Catheterization 
(n = 197) 
No. % 
185 94 
8.2 ± 0.2 
34 19 
99 54 
39 21 
10 5 
182 
24/182 13 
2/182 
331184 18 
Selective 
Catheterization 
(n = 1,461) 
No. % 
507 35 
6.2 ± 0.2 
31 8 
222 54 
116 28 
44 II 
413 
23/413 6 
6/413 
1011497 20 
p Value 
<0.001 
< 0.001 
<0.001' 
0.002 
0.73 
0.49 
'Test for comparison of distribution. LMCA = left main coronary artery. 
TIMI-II '" Thrombolysis in Myocardial Infarction Phase II Trial. 
terization group (8% versus 4%, p = 0.013), but the fre-
quency of reinfarction, death or nonfatal reinfarction and 
coronary artery revascularization procedures was similar. 
The higher hospital mortality rate in the routine catheter-
ization group (TIM! IIA hospitals) appeared to be related more 
to some as yet unidentified aspect of the TIMI IIA protocol 
Figure 1. Reasons for coronary arteriography (hierarchical display). 
Coronary arteriography was performed in 94% of the routine cath-
eterization (Cath) group and 35% of the selective catheterization 
group during the initial hospitalization. Reasons for performing 
coronary arteriography are listed in a hierarchical fashion from top 
to bottom so that patients with mUltiple reasons are counted only 
once. Ex. = exercise; MD = physician; Pt = patient. 
% of Patients 
100 94% 
80 - Protocol Mandated 947-
60 
40 
20 
o 
- Spontaneous Angina 207-
Reinfordion 27-
Positive Ex. Test 27-
~JIII~Jc~oJmplkated Clinkal Course 37-Test Not Done 17-MD Preference 67-
Routine Coth Selective Cath 
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Table 5. Complications of Procedures Performed During Initial 
Hospitalization in the Two Patient Groups 
Coronary arteriography 
Complications 
Death within 24 h 
Arterial thrombosis 
Arterial dissection 
Arterial embolus 
StrokelCNS event 
Surgery for vascular 
complication 
New occlusion 
Arrhythmia 
Pulmonary edema 
Hypotension 
Cardiac arrest 
Anaphylaxis 
Any of the above 
PTCA 
Complications 
Death within 24 h 
Myocardial infarction 
Emergency CABG 
New occlusion of IRA 
New occlusion of IRA branch 
New occlusion-other artery 
Occlusive embolization 
Other 
Any of the above 
CABG 
Complications 
Death within 24 h 
Recurrent MI 
Any of the above 
Routine 
Catheterization 
(n = 197) 
No. 
185 
2 
o 
o 
o 
o 
o 
o 
o 
o 
5 
33 
4 
o 
o 
6 
20 
% 
93.9 
1.1 
0.0 
0.5 
0.0 
0.0 
0.0 
0.5 
0.5 
0.0 
0.0 
0.0 
0.0 
2.7 
16.8 
3.0 
9.1 
12.1 
9.1 
3.0 
3.0 
0.0 
0.0 
18.2 
10.2 
5.0 
5.0 
5.0 
Selective 
Catheterization 
(n = 1,461) 
No. % 
507 34.7 
3 0.6 
0 0.0 
0 0.0 
0.2 
0 0.0 
0.2 
2 0.4 
0.2 
0.2 
6 1.2 
0 0.0 
0.2 
13 2.6 
190 13.0 
0.5 
6 3.2 
8 4.2 
7 3.7 
9 4.7 
I 0.5 
5 2.7 
II 5.8 
33 17.4 
125 8.6 
2 1.6 
7 5.6 
8 6.4 
CNS = central nervous system; IRA '" infarct-related artery; other 
abbreviations as in Tables I and 2. 
than to the hospitals performing the TIMI IIA protocol or the 
earlier time frame in which the TIMI IIA protocol was per-
formed. The hospital mortality rate for conservatively man-
aged patients at the seven hospitals participating in the TIMl 
lIA trial was 8% (16 of 197) before September 24, 1987 and 3% 
(4 of 122) when these hospitals enrolled patients in the TIMl 
lIB trial. At the 43 original hospitals participating in the TIMI 
lIB trial, the hospital mortality rate for patients assigned to 
conservative management was 4% (39 of 880) before Septem-
ber 24, 1987 versus 4% (22 of 581) afterward. 
Among the 16 patients in the routine catheterization 
group and 61 in the selective catheterization group who died 
during the initial hospitalization, death was of cardiac origin 
in 81% and 77%, respectively; pump failure was a contrib-
uting factor in 69% and 68%, respectively, of the cardiac-
related deaths. Of the 16 patients in the routine catheteriza-
tion group who died during the initial hospitalization, 7 (44%) 
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Table 6. Predischarge and 6 Week Radionuclide Ejection Fraction 
(EF) Data in the Two Patient Groups 
Predischarge radionuclide 
exercise test 
Exercise test performed 
Global EF 
Rest 
Baseline exercise 
Peak exercise 
Peak minus baseline 
Regional EF 
Rest segmental EF in 
infarct zone 
Exercise segmental EF in 
infarct zone 
6 week radionuclide exercise 
test 
Exercise test performed 
Global EF 
Rest 
Baseline exercise 
Peak exercise 
Peak minus baseline 
Regional EF 
Rest segmental EF in 
infarct zone 
Exercise segmental EF in 
infarct zone 
Routine Selective 
Catheterization Catheterization 
(n = 197) (n = 1,461) 
No. 
153 
146 
133 
132 
132 
146 
13l 
137 
129 
123 
123 
123 
128 
121 
Mean 
50 
50 
52 
2 
44 
45 
50 
49 
52 
3 
44 
44 
No. 
1,190 
1,103 
1,013 
1,014 
1,013 
1,094 
1,007 
1,114 
Mean p Value 
50 0.85 
50 0.94 
53 0.51 
3 0.20 
43 0.49 
45 0.90 
1,028 51 0.35 
0.26 
0.55 
0.52 
955 51 
954 53 
954 2 
1,020 44 0.71 
943 45 0.59 
had undergone coronary arteriography and 3 (19%) had 
undergone a revascularization procedure (angioplasty or 
bypass surgery, or both); in contrast, of the 61 patients in the 
selective catheterization group who died during the initial 
hospitalization, 14 (23%) had undergone coronary arteriog-
raphy and 8 (13%) had undergone a revascularization proce-
dure. Two of the three revascularization procedures in the 
routine catheterization group were complicated and possibly 
contributory to death, but in both patients, coronary arteri-
ography and revascularization were prompted by the occur-
rence of spontaneous recurrent ischemia. 
Events after hospital discharge (Table 7). Between initial 
hospital discharge and 1 year follow-up, death, nonfatal 
reinfarction and fatal or nonfatal reinfarction occurred with 
equal frequency in the routine and selective catheterization 
groups, but rehospitalization for cardiac reasons and the 
performance of coronary arteriography was significantly 
more common in the selective catheterization group (Fig. 2 
and 3). Angina prompted rehospitalization in 23% of the 
selective catheterization group versus 12% of the routine 
catheterization group (p < 0.001). At 1 year follow-up, the 
cumulative mortality rate was 10% in the routine catheter-
ization group compared with 7% in the selective catheteriza-
tion group (p = 0.10) and the cumulative rates of rein-
farction, death or nonfatal reinfarction were similar (Fig. 2). 
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Table 7. Clinical Outcome in the Two Patient Groups 
Mean length of initial 
hospitalization 
(days) 
Events during initial 
hospitalization' 
Death 
Nonfatal reinfarction 
Fatal or nonfatal 
reinfarction 
Death or reinfarction 
Coronary arteriography 
PTCA 
CABO 
PTCA or CABO 
Rehospitalized for 
cardiac reason 
Cardiac reasons for 
rehospitalization' , t J 
Angina pectoris 
MI 
CHF 
Arrhythmia 
Stroke 
Coronary arteriography 
PTCA 
CABO 
Other cardiac surgery 
Other cardiac reason 
Cumulative events from 
entry to I year§ 
Death 
Nonfatal reinfarction 
Fatal or nonfatal 
reinfarction 
Death or nonfatal 
reinfarction 
Coronary arteriography 
PTCA 
CABO 
PTCA or CABO 
Status at I year follow-up 
No. having I year 
follow-up visit 
Activity level same as 
pre-MI 
CCS angina class 
o 
I 
2 
3 
4 
Total 
Routine 
Catheterization 
(n = 197) 
No. % 
12 (range 0-46) 
16 8 
8 4 
9 5 
21 II 
185 94 
33 17 
20 10 
48 24 
50 28 
22 
10 
II 
5 
21 
14 
12 
o 
3 
20 
16 
18 
31 
186 
45 
34 
72 
151 
117 
119 
20 
8 
3 
151 
12 
6 
6 
12 
8 
7 
o 
2 
to 
9 
to 
16 
99 
24 
18 
39 
77 
77 
79 
13 
5 
2 
Selective 
Catheterization 
(n = 1,461) 
No. % 
11 (range 0-68) 
61 4 
65 4 
73 5 
122 8 
507 35 
190 13 
125 9 
303 21 
530 38 
317 
76 
52 
49 
7 
400 
155 
107 
7 
56 
102 
126 
139 
217 
839 
317 
232 
513 
1,091 
832 
837 
177 
55 
12 
7 
1,088 
23 
5 
4 
4 
I 
29 
11 
8 
1 
4 
7 
9 
10 
15 
59 
23 
17 
36 
75 
76 
77 
16 
5 
p Value 
0.16 
0.013 
0.80 
0.80 
0.28 
<0.001 
0.15 
0.46 
0.24 
0.007 
0.001 
0.96 
0.13 
0.61 
0.93 
<0.001 
0.17 
0.63 
0.34 
0.12 
0.10 
0.87 
0.92 
0.71 
<0.001 
0.55 
0.50 
0.46 
0.55 
0.75 
0.40 
'All percents are crude event rates. tDenominator is number surviving 
initial hospitalization (routine catheterization = 181: selective catheterization 
= 1,400). tSome patients had> 1 reason for hospitalization. §Kaplan-Meier 
event rates. CCS = Canadian Cardiovascular Society; other abbreviations as 
in Tables I and 2. 
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Figure 2. Cumulative frequency of death and reinfarction (life-table 
analyses). There was a nonsignificant trend toward a higher mortal-
ity rate in the routine (solid lines) catheterization than in the selective 
(dashed lines) group, but the combined frequency of death and 
nonfatal reinfarction in the two groups was similar. 
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The cumulative frequency of performing bypass surgery or 
angioplasty one or more times, alone or in combination, was 
similar in the two groups (Fig. 3), but the cumulative 
performance rate of coronary arteriography remained signif-
icantly higher in the routine catheterization group compared 
with the selective catheterization group (99% versus 59%, 
p < 0.001). 
Activity level and Canadian Cardiovascular Society an-
gina classification (14) at 1 year follow-up were similar 
between the two groups (Table 7), most patients reporting no 
angina and the same activity status as before acute myocar-
dial infarction. 
Discussion 
The present study demonstrates that patients with acute 
myocardial infarction selected as candidates for throm-
bolytic therapy according to Thrombolysis in Myocardial 
Infarction (TIMI) II protocol guidelines and managed con-
servatively with recombinant tissue-type plasminogen acti-
vator (rt-PA), heparin and aspirin have a predominance of 
zero and one vessel disease on predischarge arteriography. 
Although the policy of selective rather than routine coronary 
arteriography after myocardial infarction for these patients 
was associated with a higher frequency of angina prompting 
readmission for coronary arteriography over the next year, 
cumulative mortality and reinfarction rates and frequency of 
late revascularization procedures were similar at I year after 
myocardial infarction. In this observational study, a higher 
Frequency of Rehospitalization 
% of Patients 
Frequency of Coronary Arteriography 
" of Patients 
l00~~-=====-==============-1 
Figure 3. Cumulative frequency of 
rehospitalization, coronary arteriog-
raphy and revascularization proce-
dures. Although rehospitalization for 
cardiac reasons was more common in 
the selective catheterization (Cath) 
group (dashed lines) and the perfor-
mance of coronary arteriography was 
overall more common in the routine 
catheterization group (solid lines), 
both groups had similar frequencies 
of percutaneous transluminal coro-
nary angioplasty (PTCA) and coro-
nary artery bypass graft (CABG) sur-
gery. 
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initial in-hospital mortality rate-of unknown explanation-
was noted in the group undergoing routine predischarge 
arteriography. However, it seems unlikely that the arteriog-
raphy itself or invasive procedures that followed explained 
the higher mortality rate. 
Routine postinfarction arteriography. Patients surviving 
hospitalization for acute myocardial infarction are at in-
creased risk of reinfarction and death during the subsequent 
year, especially if they have extensive multivessel coronary 
artery disease jeopardizing large zones of non infarcted myo-
cardium (3,15). Patients with acute myocardial infarction 
given thrombolytic therapy in placebo-controlled trials (16-
18) have had a higher rate of reinfarction than that of 
conventionally managed control patients, and thus it has 
been proposed (2) that all patients undergoing intravenous 
thrombolytic therapy should undergo diagnostic cardiac 
catheterization before hospital discharge. 
Previous studies (19-24) performed during the pre throm-
bolytic era demonstrated that predischarge coronary arteri-
ography was associated with few complications and was 
generally accepted and often desired by patients and their 
physicians as a means of defining the coronary anatomic 
pattern responsible for the recent infarction, providing im-
portant prognostic insight and guiding recommendations for 
convalescence and return to work. A survey of cardiologists 
in 1987 (1) revealed that 86% were using coronary arteriog-
raphy routinely after uncomplicated acute myocardial infarc-
tion treated with intravenous thrombolytic agents. However, 
despite the enthusiasm for routine predischarge coronary 
arteriography, controlled trial data to verify its benefits are 
lacking. 
The present study confirms earlier reports (21-24) of the 
safety of routine predischarge coronary arteriography. 
There were no deaths directly attributable to diagnostic 
arteriography. Furthermore, although 2 of the 16 hospital 
deaths in the routine catheterization group were possibly 
related to complications occurring during angioplasty, these 
deaths occurred in patients experiencing recurrent ischemia 
after myocardial infarction who would likely have undergone 
arteriography and revascularization had they been in the 
selective catheterization group. 
Selective catheterization policy. Rather than subjecting all 
patients with recent myocardial infarction to routine predis-
charge cardiac catheterization, some reports (5,6) have 
recommended that coronary arteriography be reserved for 
patients having evidence of recurrent myocardial ischemia. 
It has been convincingly demonstrated (5) that patients at 
highest risk for death or recurrent ischemic events during the 
1st year after infarction can be identified by noninvasive 
testing at the time of hospital discharge. The TIMI II trial is 
the first large scale study to implement routine predischarge 
exercise testing for risk stratification in survivors of acute 
myocardial infarction. The TIMI II trial results reported 
herein confirm that in patients undergoing this process of 
predischarge risk stratification, death and recurrent ischemic 
events during the 1st year after hospitalization for acute 
Percent - Pre-Thrombolytic Era -
100 
257. 277. 277. 
80 417. 
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Figure 4. Number of vessels diseased. The proportion of patients 
having zero or one, two or three vessel disease (V) when predis-
charge coronary arteriography was performed within 4 weeks of 
myocardial infarction is shown. In contrast to the findings from four 
studies (15,21,22,24) during the prethrombolytic era (left), a greater 
proportion of zero or one vessel disease was observed in the present 
study (right), which employed thrombolytic therapy, intravenous 
heparin and aspirin. In the prior studies, the definition for a 
"diseased vessel" was ~50% (15,21,24) or ~70% (22) stenosis, 
whereas in the present study, ~60% stenosis (by Core Laboratory 
assessment) was considered significant. The numbers of patients 
depicted by each bar is (from left to right): 106,92, 143,259, 182 and 
412, respectively. Cath = catheterization, Ref = reference number; 
TIMI = Thrombolysis in Myocardial Infarction Phase II trial 
(present study). 
myocardial infarction are no more frequent if coronary 
arteriography is performed selectively, primarily for recur-
rent ischemia, than if it is performed routinely. 
Coronary anatomy after infarction. The present study 
demonstrated a predominance of zero «60% stenosis) and 
one vessel disease among those undergoing predischarge 
coronary arteriography in marked contrast to earlier studies 
(15,21,22,24) of predischarge coronary arteriography per-
formed during the prethrombolytic era (Fig. 4). Several 
factors may explain this observation. First, treatment with 
rt-PA, heparin and aspirin probably opened some infarct-
related arteries that otherwise would have remained oc-
cluded. Thus, in those patients in whom lysis was complete 
and residual atherosclerotic narrowing was not severe, the 
number of vessels classified as "diseased" may have been 
reduced by one. Second, in the prethrombolytic era, many 
studies of predischarge arteriography failed to obtain arte-
riograms for the majority of patients presenting with infarc-
tion, introducing a selection bias toward more symptomatic 
patients, perhaps those with more extensive coronary artery 
disease. 
Finally and most important, patients in the present study 
are themselves a selected group of patients (Table 1). To 
ensure optimal candidacy for thrombolytic therapy, the 
TIMI II trial excluded many subgroups expected to have a 
high prevalence of multivessel disease (for example, those 
with prior bypass surgery, prior angioplasty, age >75 years, 
severe hypertension, prior cerebrovascular disease and lack 
of ST elevation on admission ECG). These exclusions are 
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the most likely explanation for the high prevalence of zero or 
one vessel disease in the present study and other recent 
reports of thrombolytic therapy (25,26) and to some extent 
may explain why such patients do well after infarction. 
Rehospitalizations. The selective catheterization strategy 
was associated with a higher frequency of readmissions for 
angina pectoris during the 1st year after myocardial infarc-
tion, and during these hospitalizations, more than twice as 
many patients in the selective group underwent coronary 
arteriography as did patients in the routine catheterization 
group during the same time interval. Surprisingly, however, 
the frequency of coronary revascularization procedures dur-
ing these hospitalizations, as well as the cumulative fre-
quency of all revascularization procedures through 1 year, 
were not significantly different between the two groups. This 
observation suggests that coronary anatomic patterns judged 
clinically to need revascularization can be detected with 
equal efficacy and safety by either the routine or the selec-
tive coronary arteriography strategy. The data further sug-
gest that the "threshold" for readmitting patients with 
recurrent chest pain after infarction may be lower when 
coronary arteriography is not performed routinely during the 
initial hospitalization. The potential increased costs imposed 
by the excessive number of readmissions in the selective 
catheterization group will require further analysis. Cost data 
were not collected uniformly during TIMI II, but were 
analyzed at 3 of the 50 TIMI II hospitals (27); 1 year 
follow-up findings in these patients will be reported sepa-
rately. 
Study limitations. The TIMI II trial was not designed to 
compare the routine and selective catheterization strategies. 
The routine and selective catheterization groups analyzed in 
the present study represent two subgroups of patients en-
rolled in TIMI II according to identical entry criteria, but not 
randomized with respect to each other. Subtle differences in 
protocols, patient demographics, time to entry after onset of 
symptoms of infarction, variable duration of hospitalization 
and other unknown differences between these two nooran-
domized groups may have contributed to the observed 
differences (or lack of differences) in their outcome. It 
should be recalled that the two patient groups were for the 
most part enrolled at different hospitals and were managed 
according to slightly different ancillary therapy protocols. 
Early administration of a calcium channel antagonist was 
more prevalent in the routine catheterization group, whereas 
in the selective catheterization group, there was greater 
utilization of a beta-adrenergic blocker. These differences, 
and perhaps others not appreciated in this observational 
study, probably explain the difference in hospital survival 
between the two groups. 
The results of our large observational study correspond 
almost exactly with those of a smaller recently reported trial 
(28) of 201 patients with acute myocardial infarction who 
were treated with rt-PA, heparin and aspirin and randomized 
to receive routine coronary arteriography and angioplasty 5 
days later or to receive arteriography and angioplasty only if 
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ischemia recurred. In that study (28), similar to ours, coro-
nary arteriography was performed in 95% of the first group 
and 37% of the second. A 10 month mortality rate of 8% and 
4% (p = 0.15), respectively, was reported and a higher rate 
of readmission during the next year was observed in the 
group without predischarge coronary arteriography; how-
ever, there was no difference in left ventricular function or 
reinfarction rate. 
Clinical implications. The present study illustrates that in 
patients with acute myocardial infarction selected and 
treated according to the criteria of the TIMI II study, a 
policy of coronary arteriography reserved for those with 
pressing clinical indications such as recurrent ischemia is 
acceptable and exposes the patients to no greater risk of 
death or reinfarction than a more aggressive policy of routine 
predischarge coronary arteriography. Patients managed ac-
cording to the policy of selective coronary arteriography are 
more likely to experience angina, prompting repeat hospital-
ization for arteriography during the 1st year after myocardial 
infarction; the economic implications of these excess admis-
sions will require further study. However, despite the per-
formance of interim coronary arteriography in some pa-
tients, the policy of selective arteriography exposes about 
40% fewer patients to the small but finite risks and inconve-
nience of coronary arteriography during the 1st year after 
myocardial infarction. In the absence of data showing that 
routine predischarge arteriography improves clinical out-
come in patients after thrombolytic therapy for acute myo-
cardial infarction, we believe that selective arteriography is 
the preferable policy. 
We gratefully acknowledge the assistance of Sandra Forman. MA and Genell 
L. Knatterud, PhD in data analysis and interpretation. 
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